Enjoy complimentary customisation on priority with our Enterprise License!
The microbiomes market size is forecast to increase by USD 1132.78 million at a CAGR of 22.67% between 2024 and 2028. The market is experiencing significant growth due to the increasing prevalence of diseases that can be treated through microbiome therapeutics. The microbiome, the community of microorganisms that inhabit the human body, plays a crucial role in maintaining health and preventing diseases. The market is witnessing a significant number of collaborations between academic institutions, biotech companies, and pharmaceutical firms for developing microbiome-based therapeutics. However, challenges remain in the manufacturing and formulation of microbiome therapeutic products due to their complex nature and the need for maintaining the viability of live microorganisms. These challenges are being addressed through advancements in biotechnology and microbiology, which are expected to drive market growth in the coming years.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.